October 6, 2023 • 8 mins read TrialX Congratulates Dr. Drew Weissman, Dr. Katalin Karikó and the University of Pennsylvania! – The Nobel Prize Winning mRNA Covid Vaccine Story The Nobel Prize winning work of the mRNA covid vaccine, has an interesting story that began three decades ago, with a little-known scientist duo who…
October 19, 2020 • 2 mins read CureTalks Launches New Talk Series on Contribution of Small Biotech Companies Towards Drug Development of Orphan Diseases CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions…
July 23, 2020 • 2 mins read CureTalks launches New Video Format with a talk series on Covid-19 Research at Penn Medicine We are excited to announce that CureTalks has launched a new format with a talk series on Covid -19 in collaboration with the University…
June 17, 2019 • 3 mins read A WCG Roundtable Sharing the Progress of iConnect Patient Recruitment Platform Matching the right patient to the right trial remains the most challenging task in the success of any clinical trial. This Clinical Trials day,…
December 7, 2018 • 5 mins read We crossed a milestone! Happy 10th TrialX and Applied Informatics! October 2018 marks the 10th anniversary of TrialX Inc. and Applied Informatics Inc. Our journey officially began on 12th October, 2008, after we were…
April 27, 2018 • 3 mins read Exclusive Interview with CAR T Cell Therapy Pioneer Dr Carl June – Time’s top 100 Most Influential People in the World Time magazine named CAR-T cell therapy pioneer Dr Carl June of University of Pennsylvania in their 2018 TIME 100 annual list of the 100…
April 4, 2018 • 6 mins read Social Media in Clinical Trials – How effective? Without clinical trials we cannot expect to see any advancements in medicine; and to participate in one, patients need to be aware of ongoing…
February 4, 2018 • 8 mins read [Infographic] ASCO Names CAR-T Cell Immunotherapy Clinical Cancer Advance of the Year 2017 CAR T-Cell Immunotherapy has been named Advance of the Year in Annual ASCO Report. Cancer experts looking back over the past 12 months have…
November 14, 2017 • 6 mins read CAR-T Cell Therapy Clinical Trials – Promising Advancement in Medicine Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed by Yescarta – in August and October, respectively.…